{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:29Z","timestamp":1793500529030,"version":"4.5.0"},"reference-count":10,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.3201\/eid2307.161677","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T11:53:30Z","timestamp":1493898810000},"page":"1208-1210","source":"Crossref","is-referenced-by-count":20,"title":["Disseminated <i>Mycobacterium genavense<\/i> Infection in Patient with Adult-Onset Immunodeficiency"],"prefix":"10.3201","volume":"23","author":[{"given":"Takanori","family":"Asakura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho","family":"Namkoong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyofumi","family":"Ohkusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2307.161677-201706161154-R1","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/00002030-199310000-00009","article-title":"Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy.","volume":"7","author":"Bessesen","year":"1993","journal-title":"AIDS"},{"key":"key-10.3201\/eid2307.161677-201706161154-R2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1469-0691.2012.03817.x","article-title":"Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases.","volume":"19","author":"Hoefsloot","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2307.161677-201706161154-R3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MD.0b013e318225ab89","article-title":"Mycobacterium genavense infections: a retrospective multicenter study in France, 1996-2007.","volume":"90","author":"Charles","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"key-10.3201\/eid2307.161677-201706161154-R4","first-page":"859","article-title":"Routine rapid Mycobacterium species assignment based on species-specific allelic variation in the 65-kilodalton heat shock protein gene (hsp65).","volume":"121","author":"Pai","year":"1997","journal-title":"Arch Pathol Lab Med"},{"key":"key-10.3201\/eid2307.161677-201706161154-R5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan.","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2307.161677-201706161154-R6","doi-asserted-by":"publisher","first-page":"e3927","DOI":"10.1097\/MD.0000000000003927","article-title":"Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-\u03b3 autoantibodies and disseminated nontuberculous mycobacterial infections.","volume":"95","author":"Chi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key-10.3201\/eid2307.161677-201706161154-R7","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3201\/eid2206.151860","article-title":"Lyon TB Study Group. Interferon-\u03b3 autoantibodies as predisposing factor for nontuberculous mycobacterial infection.","volume":"22","author":"Valour","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2307.161677-201706161154-R8","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","article-title":"Anti-CD20 (rituximab) therapy for anti-IFN-\u03b3 autoantibody-associated nontuberculous mycobacterial infection.","volume":"119","author":"Browne","year":"2012","journal-title":"Blood"},{"key":"key-10.3201\/eid2307.161677-201706161154-R9","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3201\/eid1509.081259","article-title":"Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons.","volume":"15","author":"Piersimoni","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2307.161677-201706161154-R10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0732-8893(99)00014-0","article-title":"Blood and charcoal added to acidified agar media promote the growth of Mycobacterium genavense.","volume":"34","author":"Realini","year":"1999","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/23\/7\/16-1677_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:32:22Z","timestamp":1732923142000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/23\/7\/16-1677_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2307.161677","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}